Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-05-02
2009-02-17
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S013800, C514S014800, C514S015800, C514S016700, C514S017400, C530S326000, C530S327000, C530S328000, C530S329000, C530S330000, C424S057000
Reexamination Certificate
active
07491691
ABSTRACT:
Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
REFERENCES:
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4761471 (1988-08-01), Urist
patent: 4762915 (1988-08-01), Kung et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5100874 (1992-03-01), Odake et al.
patent: 5106748 (1992-04-01), Wozney et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5169837 (1992-12-01), Lagarde et al.
patent: 5187076 (1993-02-01), Wozney et al.
patent: 5403825 (1995-04-01), Lagarde et al.
patent: 5599792 (1997-02-01), Kronis et al.
patent: 5646134 (1997-07-01), Yates
patent: 5958428 (1999-09-01), Bhatnagar
patent: 5965136 (1999-10-01), Baylink
patent: 5972623 (1999-10-01), Krane et al.
patent: 6030792 (2000-02-01), Otterness et al.
patent: 6060255 (2000-05-01), Shibuya et al.
patent: 6187076 (2001-02-01), Sugahara et al.
patent: 6287816 (2001-09-01), Rosen et al.
patent: 6323146 (2001-11-01), Pugh et al.
patent: 6333312 (2001-12-01), Kuberasampath et al.
patent: 6344439 (2002-02-01), Kitamura et al.
patent: 6352973 (2002-03-01), Tam
patent: 0992586 (1999-10-01), None
patent: 50046656 (1975-04-01), None
patent: WO-90-11366 (1990-10-01), None
patent: WO 91/18098 (1991-11-01), None
patent: WO-92-03125 (1992-03-01), None
patent: WO-93/07889 (1993-04-01), None
patent: WO-93-20859 (1993-10-01), None
patent: WO 94/26893 (1994-11-01), None
patent: WO-98-12222 (1998-03-01), None
patent: WO-98-40406 (1998-09-01), None
patent: WO-02-07748 (2002-01-01), None
[Retreived from] http://web.archive.org/web/20010405155813/http://www.biospecifics.com/collagendefined.html, 2001, 2 pages {retreived on Mar. 12, 2007].
[Retreived from] “http://web.archive.org/web/20010412200503/http://www.lab.anhb.uwa.edu.au/mb140/CorePages/Connective/Connect.htm” 2001, 10 pages, [Retreived on Mar. 9, 2007].
[Retreived from] http://web.archive.org/web/20020606150054, 2002. 2 pages [retreived on Mar. 12, 2007].
Nachman et al., Pseudodoipeptide analogs of the pyrokinin/PBAN (FXPRLa) insect neuropeptide family containing carbocyclic Pro-mimetic conformational components, Regulatory Peptides, 1995, 359-370, 57.
Pugh Sydney M.
Sindrey Dennis R.
Smith Timothy J. N.
Gudibande Satyanarayana R
Kosar Andrew D
Pandiscio & Pandiscio
LandOfFree
Connective tissue stimulating peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Connective tissue stimulating peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Connective tissue stimulating peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4103406